Evidence map›Paper›PMID 40175486›Full record

ArticleScientific reports2025

Associations between past infectious mononucleosis diagnosis and 47 inflammatory and vascular stress biomarkers.

Ragnar P Kristjánsson, Jojo Biel-Nielsen Dietz, Ólafur B Davíðsson, Bertram Kjerulff, Klaus Rostgaard, Joseph Dowsett, Signe Holst Søegaard, Emelie Curovic Rotbain, Michael Schwinn, Kristoffer Sølvsten Burgdorf and 13 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Ragnar P KristjánssonDanish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark. ragkri@cancer.dk.
Jojo Biel-Nielsen DietzDanish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
Ólafur B DavíðssonDanish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
Bertram KjerulffDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Klaus RostgaardDanish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
Joseph DowsettDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Signe Holst SøegaardDanish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
Emelie Curovic RotbainDanish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
Michael SchwinnDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Kristoffer Sølvsten BurgdorfTranslational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jakob Thaning BayDepartment of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
Christina MikkelsenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Henrik UllumStatens Serum Institut, Copenhagen, Denmark.
Søren BrunakTranslational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Erik SørensenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Bitten Aagaard JensenDepartment of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Mie Topholm BruunDepartment of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Mette NyegaardStatens Serum Institut, Copenhagen, Denmark.
Sisse Rye OstrowskiDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Ole Birger PedersenDepartment of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Thomas Folkmann HansenTranslational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Henrik HjalgrimDanish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious mononucleosis (IM), predominantly caused by primary Epstein-Barr virus (EBV) infection, is a common disease in adolescents and young adults. EBV infection is nearly ubiquitous globally. Although primary EBV infection is asymptomatic in most individuals, IM manifests in a subset infected during adolescence or young adulthood. IM occurrence is linked to sibship structure, and is associated with increased risk of multiple sclerosis, other autoimmune diseases, and cancer later in life. We analyzed 47 biomarkers in 5,526 Danish individuals aged 18-60 years, of whom 604 had a history of IM, examining their associations with IM history up to 48 years after IM diagnosis. No significant long-term associations were observed after adjusting for multiple comparisons. When restricting the analysis to individuals measured within 10 years post-IM diagnosis, a statistically significant increase in CRP levels was observed in females. This association was not driven by oral contraceptive use. No significant associations between sibship structure and biomarker levels were detected. In conclusion, our study shows that while IM may lead to a transient increase in CRP levels in females, it does not result in long-term alterations in plasma biomarkers related to immune function, suggesting other mechanisms may be responsible for the long-term health impacts associated with IM.

Indexed as

BiomarkersInfectious MononucleosisInflammationAdolescentAdultC-Reactive ProteinDenmarkFemaleHerpesvirus 4, HumanHumansMaleMiddle AgedYoung AdultBiomarkersC-Reactive Protein

Identifiers

PMID40175486
PMCPMC11965513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.